Reuters reports that large, cash-rich corporates have recently begun lending to cash-strapped banks through the repo market, with Johnson & Johnson, Pfizer and Peugeot some of the latest investment grade corporates to establish repo programmes. The article quotes an unnamed source as saying that corporates now provide 25% of some funding deals.
Cash-rich corporates represent one of the few available sources of funding for European banks, which have largely stopped lending to each other, the article notes. For the industrial companies, repo represents a safer alternative to placing money on unsecured deposit with a bank.


It is recommended that you do not log out if you regularly access Creditflux on this computer.
Once you have logged out you will need to re-register by entering your email address and receiving an email from us to gain access.
Click here if you are sure you want to log out.

Already a registered user? Click here to login.

This article is only available
to Creditflux subscribers.
Already a subscriber? Click here.
As a part of your trial subscription
you will receive:


Bookmarking this article will save it in your membership area for your reference at a later date. You can bookmark as many articles as you like.
To access your membership area click here or on 'Manage My Account' located in the top right hand corner of any page. You must be logged into the site to use this feature.
For help, please contact us on
+44(0) 20 7253 9510.
Have J&J, Pfizer, and Peugeot not gotten the memo? While it's certainly a bad idea to lend unsecured to European banks, don't bet your balance sheet on repo, either. If cash-rich companies go with repo, then they should be careful what collateral types they accept. Don't take anything other than Bunds and Gilts.